| Year |
Citation |
Score |
| 2021 |
Price BR, Johnson LA, Norris CM. Reactive Astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease. Ageing Research Reviews. 101335. PMID 33812051 DOI: 10.1016/j.arr.2021.101335 |
0.313 |
|
| 2020 |
Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, Wilcock DM. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. Journal of Neuroinflammation. 17: 238. PMID 32795308 DOI: 10.1186/s12974-020-01915-0 |
0.716 |
|
| 2020 |
Weekman EM, Lee T, Price BR, Woolums AE, Hawthorne D, IV CES, Wilcock DM. Hyperhomocysteinemia as a model of VCID Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039888 |
0.663 |
|
| 2019 |
Weekman EM, Sudduth TL, Price BR, Woolums AE, Hawthorne D, Seaks CE, Wilcock DM. Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events. Journal of Neuroinflammation. 16: 284. PMID 31888650 DOI: 10.1186/s12974-019-1685-z |
0.709 |
|
| 2019 |
Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, ... ... Price BR, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer's & Dementia (New York, N. Y.). 5: 107-117. PMID 31011621 DOI: 10.1016/J.Trci.2019.02.001 |
0.603 |
|
| 2019 |
Price BR, Sudduth TL, Weekman EM, Woolums A, Hawthorne D, Rosenthal A, Wilcock DM. THERAPEUTIC TARGETING OF TREM2 BY AN ACTIVATING ANTIBODY AMELIORATES AMYLOID-BETA DEPOSITION AND IMPROVES COGNITION IN THE 5XFAD MODEL OF ALZHEIMER’S DISEASE Alzheimer's & Dementia. 15: P214. DOI: 10.1016/j.jalz.2019.06.4559 |
0.713 |
|
| 2018 |
Price BR, Wilcock DM, Weekman EM. Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia. Frontiers in Aging Neuroscience. 10: 350. PMID 30429785 DOI: 10.3389/fnagi.2018.00350 |
0.701 |
|
| 2017 |
Price BR, Norris CM, Sompol P, Wilcock DM. An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia (VCID). Journal of Neurochemistry. PMID 29222909 DOI: 10.1111/Jnc.14273 |
0.619 |
|
| 2017 |
Price BR, Sudduth TL, Weekman EM, Wilcock DM, Woolums A. [P1–004]: ASTROCYTE RESPONSE TO HYPERHOMOCYSTEINEMIA (HHCY) Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.06.071 |
0.682 |
|
| 2017 |
Price BR, Sudduth TL, Weekman EM, Wilcock DM, Woolums A. [P1–198]: ASTROCYTE RESPONSE TO HYPERHOMOCYSTEINEMIA (HHCY) Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.06.018 |
0.682 |
|
| 2016 |
Sudduth TL, Weekman EM, Price BR, Gooch JL, Woolums A, Norris CM, Wilcock DM. Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID). Neuroscience. PMID 27890830 DOI: 10.1016/J.Neuroscience.2016.11.024 |
0.727 |
|
| 2006 |
Price BR, Sudduth TL, Dickey CA, Wilcock DM. P3-205: AN EMERGING ROLE FOR HSP27 IN VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA (VCID) Alzheimer's & Dementia. 14: P1146-P1146. DOI: 10.1016/j.jalz.2018.06.1564 |
0.558 |
|
| Show low-probability matches. |